Faculty

9I�� Innovation Fund (MIF) information session (MEDICINE)

admin — Wed, 30 Jul 2025 15:43:14 +0000

The next application window of the MIF will open on September 22, 2025. This in-person session aims to explain the MIF program to potential applicants, and to provide an overview of the application process.

Caring Conversations: The Compassionate Lie

admin — Mon, 15 Sep 2025 20:25:42 +0000

Caring Conversations is an online forum for caregivers of people living with dementia to learn from experts, share concerns and ask questions.

Seminar Series: Jennifer Estall, Ph.D.

admin — Mon, 15 Sep 2025 19:34:08 +0000

Seminar Announcement

Jennifer Estall, Ph.D.

Research Professor

The Potential Role of Technology in the Provision of Health Care to Older Patients

admin — Mon, 15 Sep 2025 18:37:00 +0000

The Potential Role of Technology in the Provision of Health Care to Older Patients

Call for Applications: International Partnerships Program

admin — Thu, 14 Aug 2025 14:41:03 +0000

D2R | DNA to RNA is launching the International Partnerships Program (IPP) to strengthen large-scale, multi-institutional collaborations with leading global organizations. This strategic funding program supports partnerships that align with D2R’s mission, offer complementary expertise, and provide enriched, multidisciplinary training environments. The program will prioritize initiatives with strong institutional commitment, alignment with D2R’s research priorities, and potential for high global impact.

Provost honours 31 9I�� professors for exceptional research achievements

admin — Thu, 01 May 2025 16:23:55 +0000

9I�� announces 2025 cohort of Distinguished James 9I�� Professors, James 9I�� Professors and William Dawson Scholars
Provost and Vice-President (Academic) Christopher Manfredi has named 31 9I�� professors as Distinguished James 9I�� Professors, James 9I�� Professors or William Dawson Scholars. The internal awards recognize exceptional research achievements.

Event | Seminar: Computer-based Predictions of RNA Structures: Where do we stand?

admin — Thu, 04 Sep 2025 13:11:03 +0000

Join D2R for this hybrid seminar with Professor Eric Westhof from University of Strasbourg

Physiology professor Claire M. Brown appointed inaugural Chair for Inclusion in Science and Engineering

admin — Tue, 09 Sep 2025 19:52:07 +0000

Claire M. Brown, Professor in the Department of Physiology, has been selected as Chair for Inclusion in Science and Engineering (CISE) in the province of Quebec. The newly established CISE program is jointly funded by the Natural Sciences and Engineering Research Council (NSERC) and the Fonds de recherche du Québec – Nature et technologies (FRQNT).

The Child Phonology Lab at SCSD is looking for parent participants

admin — Thu, 15 May 2025 16:14:23 +0000

Professor Simon Roy wins Marathon of Hope Clinician-Scientist Award for melanoma research

admin — Tue, 26 Aug 2025 15:17:53 +0000

Simon Roy, Assistant Professor in the Department of Pathology, is one of four early-career clinician-scientists across Canada to receive the 2025 Clinician-Scientist Award from the Marathon of Hope Cancer Centres Network (MOHCCN).

9I��’s President honours outstanding early-career researchers

admin — Thu, 29 May 2025 15:48:45 +0000

Professors Guojun Chen, Mahsa Dadar and Phoebe Friesen – all members of the Faculty of Medicine and Health Sciences – win President’s Prize for Outstanding Emerging Researchers

Three 9I�� scholars were recognized with the 2025 President’s Prize for Outstanding Emerging Researchers at the Health Sciences Convocation Ceremony on May 27. The award honours exceptional early-career researchers whose work is expanding the frontiers of knowledge in their fields.

D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer

admin — Wed, 26 Mar 2025 11:03:15 +0000

Montreal, March 26, 2025 – 9I��’s DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on March 13, 2025.

Call for Letters of Intent: Translational Impact Research Program | Cycle 2

admin — Wed, 27 Aug 2025 14:56:59 +0000

D2R | DNA to RNA is launching the next round of funding for the Translational Impact Research (TIR) program. This program supports a select few large-scale translational research projects in RNA-based therapeutics which are expected to have a measurable impact on the health of Canadians. Projects must address the D2R Initiative’s strategic priorities and priority disease areas: oncology, rare diseases, infectious diseases, cardiovascular and cardiometabolic diseases.

Applicant Eligibility:

This competition is open to:

Human genetics professor receives Banting Discovery Award

admin — Mon, 02 Jun 2025 16:06:00 +0000

Cross-pollinating ideas at the SCSD Research Day

admin — Thu, 27 Mar 2025 18:49:49 +0000

Student presenters at the SCSD Research Day, which took place on February 21, 2025.